N
OMIC

Nuveen’s Singular Genomics Systems, Inc. Common Stock OMIC Stock Holding History

Nuveen’s Portfolio OMIC Stock Details OMIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-7,347
Closed -$267K – 3326
2023
Q1 		$267K Buy
7,347
+13
+0.2% +$796 ﹤0.01% 2938
2022
Q4 		$442K Sell
7,334
-628
-8% -$42.1K ﹤0.01% 2913
2022
Q3 		$597K Buy
7,962
+189
+2% +$19.7K ﹤0.01% 2922
2022
Q2 		$891K Buy
7,773
+4,728
+155% +$555K ﹤0.01% 2839
2022
Q1 		$579K Buy
3,045
+2,541
+504% +$588K ﹤0.01% 2974
2021
Q4 		$171K Hold
504
– – ﹤0.01% 3253
2021
Q3 		$169K Buy
+504
New +$258K ﹤0.01% 3289

Other funds holding OMIC

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Nuveen's OMIC Position: Q2 2023 in Review

Nuveen sold out of Singular Genomics Systems, Inc. Common Stock (OMIC) in Q2 2023, closing a stake of 7,347 shares — an estimated $267K sold.

Nuveen first reported a position in OMIC in Q3 2021 and held it in 7 quarters. The position peaked at $891K in Q2 2022. 62 funds tracked by Wall St. Rank hold OMIC as of Q2 2023.

  • Nuveen reported no remaining Singular Genomics Systems, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Nuveen sold 7,347 Singular Genomics Systems, Inc. Common Stock shares in Q2 2023, an estimated $267K.
  • Nuveen first reported a position in Singular Genomics Systems, Inc. Common Stock in Q3 2021 and held it in 7 quarters.
  • Nuveen's Singular Genomics Systems, Inc. Common Stock position peaked at $891K in Q2 2022.
  • 62 funds tracked by Wall St. Rank held Singular Genomics Systems, Inc. Common Stock as of Q2 2023.

Based on Nuveen's 13F filing for Q2 2023, filed 14 Aug 2023.